{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T19:55:32Z","timestamp":1769284532736,"version":"3.49.0"},"reference-count":12,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2016,8,27]],"date-time":"2016-08-27T00:00:00Z","timestamp":1472256000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2016,8,27]],"date-time":"2016-08-27T00:00:00Z","timestamp":1472256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Lab. Anal."],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1002\/jcla.22040","type":"journal-article","created":{"date-parts":[[2016,8,27]],"date-time":"2016-08-27T06:46:43Z","timestamp":1472280403000},"page":"e22040","source":"Crossref","is-referenced-by-count":5,"title":["APOE Variants E2, E3, and E4 Can Be Miscalled By Classical PCR-RFLP When The Christchurch Variant Is Also Present"],"prefix":"10.1002","volume":"31","author":[{"given":"Beatriz","family":"Cand\u00e1s-Est\u00e9banez","sequence":"first","affiliation":[{"name":"Hospital Universitari de Bellvitge; Laboratori Cl\u00ednic; L'Hospitalet de Llobregat Catalunya Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariadna","family":"Padr\u00f3-Miquel","sequence":"additional","affiliation":[{"name":"Hospital Universitari de Bellvitge; Laboratori Cl\u00ednic; L'Hospitalet de Llobregat Catalunya Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Ruiz-Iruela","sequence":"additional","affiliation":[{"name":"Hospital Universitari de Bellvitge; Laboratori Cl\u00ednic; L'Hospitalet de Llobregat Catalunya Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emili","family":"Corbella-Ingl\u00e9s","sequence":"additional","affiliation":[{"name":"Cardiovascular Risk Unit, Internal Medicine; Hospital Universitari de Bellvitge; L'Hospitalet de Llobregat Catalunya Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Pint\u00f3-Sala","sequence":"additional","affiliation":[{"name":"Cardiovascular Risk Unit, Internal Medicine; Hospital Universitari de Bellvitge; L'Hospitalet de Llobregat Catalunya Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Al\u00eda-Ramos","sequence":"additional","affiliation":[{"name":"Hospital Universitari de Bellvitge; Laboratori Cl\u00ednic; L'Hospitalet de Llobregat Catalunya Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,8,27]]},"reference":[{"key":"10.1002\/jcla.22040-BIB0001|jcla22040-cit-0001","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/humu.1380040303","article-title":"Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels","volume":"4","author":"Knijff","year":"1994","journal-title":"Hum Mutat"},{"key":"10.1002\/jcla.22040-BIB0002|jcla22040-cit-0002","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0022-2275(20)43176-1","article-title":"Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI","volume":"31","author":"Hixson","year":"1990","journal-title":"J Lipid Res"},{"key":"10.1002\/jcla.22040-BIB0003|jcla22040-cit-0003","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S0022-2275(20)38060-3","article-title":"Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2\/2","volume":"23","author":"Breslow","year":"1982","journal-title":"J Lipid Res"},{"key":"10.1002\/jcla.22040-BIB0004|jcla22040-cit-0004","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1016\/S0021-9258(18)34954-8","article-title":"Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site","volume":"257","author":"Weisgraber","year":"1982","journal-title":"J Biol Chem"},{"key":"10.1002\/jcla.22040-BIB0005|jcla22040-cit-0005","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0140-6736(83)91653-7","article-title":"Apolipoprotein E alleles in severe Hypertriglyceridaemia","volume":"321","author":"Gregg","year":"1983","journal-title":"Lancet"},{"key":"10.1002\/jcla.22040-BIB0006|jcla22040-cit-0006","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1399-0004.1989.tb03186.x","article-title":"Increased frequencies of apolipoprotein E2 and E4 alleles in patients with ischemic heart disease","volume":"36","author":"Eto","year":"1989","journal-title":"Clin Genet"},{"key":"10.1002\/jcla.22040-BIB0007|jcla22040-cit-0007","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0925-4439(00)00096-X","article-title":"Apolipoprotein E4 stimulates sulfation of glycosaminoglycans in neural cells","volume":"1535","author":"Bonay","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"10.1002\/jcla.22040-BIB0008|jcla22040-cit-0008","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1212\/01.WNL.0000042478.08543.F7","article-title":"Apolipoprotein E epsilon-4 allele, AD pathology, and the clinical expression of Alzheimer's disease","volume":"60","author":"Bennett","year":"2003","journal-title":"Neurology"},{"key":"10.1002\/jcla.22040-BIB0009|jcla22040-cit-0009","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1172\/JCI113096","article-title":"New variant if human apolipoptotein E in a patient with type III hyperlipoproteinemia","volume":"80","author":"Wardell","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1002\/jcla.22040-BIB0010|jcla22040-cit-0010","doi-asserted-by":"crossref","first-page":"573","DOI":"10.33549\/physiolres.930687","article-title":"Rare variant of apolipoprotein E (Arg136-Ser) in two normolipidemic individuals","volume":"54","author":"Hub\u00e1cek","year":"2005","journal-title":"Physiol Res"},{"key":"10.1002\/jcla.22040-BIB0011|jcla22040-cit-0011","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0021-9150(95)06745-0","article-title":"Incomplete dominance of type III hyperlipoprotinemia is associated with the rare apolipoprotein E2 (Arg136-Ser) variant in multidgenerational pedigree studies","volume":"122","author":"Pocovi","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1002\/jcla.22040-BIB0012|jcla22040-cit-0012","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/clinchem\/40.1.24","article-title":"Common and rare genotypes of human apolipoprotein E determined by specific restriction profiles of polymerase chain reaction-amplified DNA","volume":"40","author":"Richard","year":"1994","journal-title":"Clin Chem"}],"container-title":["Journal of Clinical Laboratory Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcla.22040","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcla.22040","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/jcla.22040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T21:36:30Z","timestamp":1692480990000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcla.22040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,27]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"URL":"https:\/\/doi.org\/10.1002\/jcla.22040","archive":["Portico"],"relation":{},"ISSN":["0887-8013"],"issn-type":[{"value":"0887-8013","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8,27]]}}}